Search research articles
Contact Us
Filters
Showing results (541-550 of 560) with videos related to
Page
of 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Normal Risk Ovarian Screening Study: 21-Year Update
Chae Young Han, Karen H Lu, Gwen Corrigan, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Chemistry
|
December 2, 2008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
Catharine M Sturgeon, Michael J Duffy, Ulf-Håkan Stenman, et al.
Cancers
|
July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer
Chae Young Han, David A Patten, Se Ik Kim, et al.
JAMA Network Open
|
October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Katelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer
Claire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Nature Communications
|
June 10, 2022
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
Yiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Plos Genetics
|
June 5, 2020
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
Olga Kim, Eun Young Park, David L Klinkebiel, et al.
Nature Communications
|
February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
Yiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
JCI Insight
|
May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
Mara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 560) with videos related to
Sort By:
Page
of 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Normal Risk Ovarian Screening Study: 21-Year Update
Chae Young Han, Karen H Lu, Gwen Corrigan, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Chemistry
|
December 2, 2008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
Catharine M Sturgeon, Michael J Duffy, Ulf-Håkan Stenman, et al.
Cancers
|
July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer
Chae Young Han, David A Patten, Se Ik Kim, et al.
JAMA Network Open
|
October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Katelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer
Claire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Nature Communications
|
June 10, 2022
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
Yiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Plos Genetics
|
June 5, 2020
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
Olga Kim, Eun Young Park, David L Klinkebiel, et al.
Nature Communications
|
February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
Yiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
JCI Insight
|
May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
Mara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Page
of 56